Researchers have identified ALB and GLB levels and the albumin-to-globulin ratio (AGR) as valuable prognostic markers in patients with various cancers, including colorectal cancer 8, brain tumor 9, urothelial cancer 10, and gastric and lung cancer 11, 12. This evidence concerns the gene ALB and brain neoplasm.